Is nasal high flow (NHF) suitable/ recommended for the treatment of COVID-19?
Yes.
The World Health Organization (WHO), European Respiratory Society (ERS) National Institutes of Health (NIH), the Australia and New Zealand Intensive Care Society (ANZICS) and the Surviving Sepsis Campaign (SSC) recommend NHF for use in COVID-19-related hypoxemia.
In addition, a recent recommendation for hospital preparedness calls for advocacy of the use of NHF.